Golestan University of Medical Sciences Repository

Measures of mortality in coronavirus (COVID-19) compared with SARS and MERS

Kalteh, E.A. and Sofizadeh, A. and Fararooei, M. and Ghojogh, M.G. and Aljalili, S. (2020) Measures of mortality in coronavirus (COVID-19) compared with SARS and MERS. Journal of Cellular and Molecular Anesthesia, 5 (2). pp. 97-101.

Full text not available from this repository.


In late 2019, a novel coronavirus, now designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China. Mortality rate, case fatality rate, and Years of Potential Life Lost can be measured by determining death cases. Much of our information on mortality rates of diseases can be obtained through a regular implementation of care plans that are often developed to screen infectious diseases. In the YLL component, the higher the individuals die at an earlier age, the longer their life is lost. For COVID-19, this component refers to the simple subtraction of age at death due to COVID-19 from the standardized life expectancy for the same age in the same sex. A potential application of health summary indices is to consider the non-fatal consequences of diseases to ensure that they are taken into account in health policy making. Given that COVID-19 has a non-fatal effect on a large number of patients, the estimation of disease burden using the DALYs may be an appropriate index for achieving this goal. © 2020 Journal of Cellular and Molecular Anesthesia.

Item Type: Article
Additional Information: cited By 1
Subjects: بیماریهای واگیرWC
میکروب شناسی وایمنی شناسی QW
بهداشت عمومی WA > آمار حیاتیWA
مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: معاونت تحقیقات و فناوری
Depositing User: GOUMS
Date Deposited: 19 Oct 2020 10:15
Last Modified: 19 Oct 2020 10:15
URI: http://eprints.goums.ac.ir/id/eprint/10823

Actions (login required)

View Item View Item